• Margin trajectory: EBITDA margins reached nearly 24% in the previous quarter and are expected to continue improving quarter-on-quarter via operating leverage across multiple sectors, with no sacrifice to gross margins.
• CapEx financing: The company's ₹500 crore CapEx pipeline for FY27 and FY28 is progressing on schedule and will be funded approximately 30% to 35% through internal accruals, with the balance financed by debt.
• Bloom Energy execution: MTAR is actively scaling manufacturing capacity to match high demand from Bloom Energy and expects to fulfill requirements on time without facing supply constraints or execution delays.
• Nuclear sector growth: The company has an all-time high nuclear order book of over ₹800 crore, anticipating a partial revenue ramp-up in the second half and a substantial acceleration starting next year from new reactor projects like Mahi Banswara.